Quantum Biopharma Ltd. (QNTM)

PriceLoading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

7 annual periodsNewest to oldest
2025202420232022202120202019
Research & development$2.8M$6.1M$3.9M$6.9M$6.3M$7.8M$0
Operating expenses$15.3M$16.1M$23.8M$27.4M$33.7M
Operating income−$15.3M−$16.1M−$23.8M−$27.4M−$33.7M−$30.7M−$22.5M
EBITDAderived−$14.8M−$15.6M−$21.3M−$22.9M−$29.7M−$26.8M−$20.5M
Net income−$23.6M−$35.3M−$31.8M−$39.1M

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.